Update in Cardiology
Authors: William H. Frishman
Journal: Annals of Internal Medicine (2001)

Updates from the Annual Session18 September 2001Update in CardiologyWilliam H. Frishman, MDWilliam H. Frishman, MDFrom New York Medical College/Westchester Medical Center,Valhalla, New York.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-6-200109180-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This year's Update in Cardiology features key reports in major areas of cardiovascular medicine: prevention, unstable coronary syndromes, chronic cardiovascular disease, arrhythmias, and peripheral vascular disease. Most of the papers reviewed are reports from large clinical trials, which are common in this field because of the wide prevalence of heart disease. Thus, it is often possible to make evidence-based management recommendations that are based directly on experience in large-scale trials.Prevention of Cardiovascular DiseaseDiuretic Therapy Outperformed an α-Blocker, Especially for Prevention of Heart Failure, in Patients at Risk for Coronary Heart DiseaseMajor cardiovascular events in hypertensive patients randomized to ...References1. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al . Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87. [PMID: 11419424] CrossrefMedlineGoogle Scholar2. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022-36. [PMID: 1191416] CrossrefMedlineGoogle Scholar3. Frishman WH. Carvedilol. N Engl J Med. 1998;339:1759-65. [PMID: 9845712] CrossrefMedlineGoogle Scholar4. Heidenreich PA, Lee TT, Massie BM. Effect of β-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27-34. [PMID: 9207617] CrossrefMedlineGoogle Scholar5. Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, et al . Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999;99:990-2. [PMID: 10051289] CrossrefMedlineGoogle Scholar6. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;343:1206-9. [PMID: 11071670] CrossrefMedlineGoogle Scholar7. . Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109. [PMID: 9492970] CrossrefMedlineGoogle Scholar8. Warshafsky S, Packard D, Marks SJ, Sachdeva N, Terashita DM, Kaufman G, et al . Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke. J Gen Intern Med. 1999;14:763-74. [PMID: 10632823] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From New York Medical College/Westchester Medical Center,Valhalla, New York.Corresponding Author: William H. Frishman, MD, New York Medical College/Westchester Medical Center, Valhalla, NY 10595. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 September 2001Volume 135, Issue 6Page: 439-446KeywordsACE inhibitorsAtrial fibrillationCoronary heart diseaseHeart failureLongitudinal studiesMortalityMyocardial infarctionRelative riskStable coronary artery diseaseStroke ePublished: 18 September 2001 Issue Published: 18 September 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...